Asset Management One’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30,192
Closed -$2.22M 1062
2022
Q1
$2.22M Sell
30,192
-161
-0.5% -$14.4K 0.01% 783
2021
Q4
$4.64M Sell
30,353
-630
-2% -$108K 0.02% 693
2021
Q3
$6.42M Buy
30,983
+282
+0.9% +$62.2K 0.02% 587
2021
Q2
$6.52M Buy
+30,701
New +$5.62M 0.02% 599
2016
Q3
Sell
-32,326
Closed -$4.63M 1341
2016
Q2
$4.63M Buy
32,326
+833
+3% +$95.5K 0.07% 324
2016
Q1
$3.24M Buy
31,493
+16,075
+104% +$1.72M 0.05% 450
2015
Q4
$2.68M Buy
+15,418
New +$2.37M 0.04% 502

Other funds holding NVAX

Asset Management One's NVAX Position: Q2 2022 in Review

Asset Management One sold out of Novavax (NVAX) in Q2 2022, closing a stake of 30,192 shares — an estimated $2.22M sold.

Asset Management One first reported a position in NVAX in Q4 2015 and held it in 7 quarters. The position peaked at $6.52M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Asset Management One reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Asset Management One sold 30,192 Novavax shares in Q2 2022, an estimated $2.22M.
  • Asset Management One first reported a position in Novavax in Q4 2015 and held it in 7 quarters.
  • Asset Management One's Novavax position peaked at $6.52M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Asset Management One's 13F filing for Q2 2022, filed 29 Jul 2022.